Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Sodium Chloride × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Pain, Postoperative 2 Lymphoma, Non-Hodgkin 2 Leiomyoma 2 Hodgkin Disease 2 Surgical Wound 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sigmoid Neoplasms 1 Rectal Neoplasms 1 Radiodermatitis 1 Platinum Resistant Ovarian Cancer 1 Pharyngitis 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neuroinflammatory Diseases 1 Neoplasms 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lung Neoplasms 1 Lung Injury 1 Locally Advanced Cervical Cancer 1 Limited Stage Small Cell Lung Cancer 1

Interventions

pembrolizumab 38 Gemcitabine 20 enfortumab vedotin 19 Cisplatin 17 Nivolumab 16 atezolizumab 14 Magnetic Resonance Spectroscopy 14 avelumab 13 Carboplatin 12 Specimen Handling 10 Docetaxel 10 sacituzumab govitecan 9 Paclitaxel 7 Ipilimumab 7 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 erdafitinib 3 durvalumab 3 cabozantinib 3 X-Rays 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 eribulin 2 dodecyl maltoside 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡